Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell CarcinomaThai Huu Ho, Payal Kapur, Jeanette E Eckel-Passow, et al.
Clinical Genitourinary Cancer|September 16, 2018
Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry StudySolomon L Woldu, Justin T Matulay, Timothy N Clinton, et al.
Urologic Oncology|September 17, 2019
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinomaNirmish Singla, Roy Elias, Rashed A Ghandour, et al.
Clinical Genitourinary Cancer|July 17, 2020
Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary ExperienceDurgesh K Dwivedi, Yin Xi, Payal Kapur, et al.
Genes|July 25, 2019
SCINA: A Semi-Supervised Subtyping Algorithm of Single Cells and Bulk SamplesZe Zhang, Danni Luo, Xue Zhong, et al.
Nature Medicine|May 25, 2004
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathwaysPradip K Majumder, Phillip G Febbo, Rachel Bikoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2014
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesisShan-Shan Wang, Yi-Feng Gu, Nicholas Wolff, et al.
Cancer Research|April 19, 2024
GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell CarcinomaDazhi Wang, Iqbal Mahmud, Vijay S Thakur, et al.
The Journal of Clinical Investigation|March 24, 2026
Genome-wide CRISPR screen identifies a cytokine-enhancer circuit driving HIF-2α activation in renal cancerJun Fang, Jeremy M Simon, Tao Wang, et al.
Urologic Oncology|December 4, 2014
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinomaThai H Ho, Payal Kapur, Richard W Joseph, et al.
Pageof 18